Use of Blinatumomab for Relapse Therapy of B-Cell Precursor Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pawinska-Wasikowska, K. [1 ,2 ]
Wyrobek, E. [2 ]
Klekawka, T. [1 ,2 ]
Luszawska-Kutrzeba, T. [2 ]
Garus, K. [2 ]
Pietrys, D. [2 ]
Zaniewska-Tekieli, A. [2 ]
Wieczorek, A. [1 ,2 ]
Balwierz, W. [1 ,2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Pediat Oncol & Hematol, Inst Pediat, Krakow, Poland
[2] Childrens Univ Hosp Krakow, Dept Pediat Oncol & Hematol, Krakow, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V177 SIOP1
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [1] Immunological Response of Children With Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia to Blinatumomab
    Pawinska-Wasikowska, K.
    Bukowska-Strakova, K.
    Surman, M.
    Siedlar, M.
    Balwierz, W.
    Skoczen, S.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S480 - S481
  • [2] Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults
    Lee, Kum Ja
    Chow, Vivian
    Weissman, Ashley
    Tulpule, Sunil
    Aldoss, Ibrahim
    Akhtari, Mojtaba
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1301 - 1310
  • [3] Blinatumomab approved as consolidation therapy for MRD-negative B-cell precursor acute lymphoblastic leukemia
    Nierengarten, Mary Beth
    CANCER, 2024, 130 (21) : 3622 - 3622
  • [4] CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
    E. Mejstríková
    O. Hrusak
    M. J. Borowitz
    J. A. Whitlock
    B. Brethon
    T. M. Trippett
    G. Zugmaier
    L. Gore
    A. von Stackelberg
    F. Locatelli
    Blood Cancer Journal, 7
  • [5] CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
    Mejstrikova, E.
    Hrusak, O.
    Borowitz, M. J.
    Whitlock, J. A.
    Brethon, B.
    Trippett, T. M.
    Zugmaier, G.
    Gore, L.
    von Stackelberg, A.
    Locatelli, F.
    BLOOD CANCER JOURNAL, 2017, 7
  • [6] Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Kantarjian, Hagop M.
    Brueggemann, Monika
    Stein, Anthony S.
    Bargou, Ralf C.
    Dombret, Herve
    Fielding, Adele K.
    Heffner, Leonard
    Rigal-Huguet, Francoise
    Litzow, Mark
    O'Brien, Susan
    Zugmaier, Gerhard
    Gao, Shan
    Nagorsen, Dirk
    Forman, Stephen J.
    Topp, Max S.
    BLOOD ADVANCES, 2019, 3 (20) : 3033 - 3037
  • [7] Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab
    Queudeville, Manon
    Handgretinger, Rupert
    Ebinger, Martin
    ONCOTARGETS AND THERAPY, 2017, 10 : 3567 - 3578
  • [8] Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Dombret, Herve
    Bonifacio, Massimiliano
    Reichle, Albrecht
    Graux, Carlos
    Faul, Christoph
    Diedrich, Helmut
    Topp, Max S.
    Brueggemann, Monika
    Horst, Heinz-August
    Havelange, Violaine
    Stieglmaier, Julia
    Wessels, Hendrik
    Haddad, Vincent
    Benjamin, Jonathan E.
    Zugmaier, Gerhard
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2018, 131 (14) : 1522 - 1531
  • [9] Blinatumomab in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Queudeville, Manon
    Schlegel, Patrick
    Heinz, Amadeus T.
    Lenz, Teresa
    Doering, Michaela
    Holzer, Ursula
    Hartmann, Ulrike
    Kreyenberg, Hermann
    von Stackelberg, Arend
    Schrappe, Martin
    Zugmaier, Gerhard
    Feuchtinger, Tobias
    Lang, Peter
    Handgretinger, Rupert
    Ebinger, Martin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 473 - 483
  • [10] Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia
    Wolach, Ofir
    Stone, Richard M.
    CLINICAL CANCER RESEARCH, 2015, 21 (19) : 4262 - 4269
12345